Treat COVID-19 with drugs using new technology

Abstract

Severe acute respiratory syndrome caused by Corona virus 2 (SARS-CoV-2), announced by WHO as a global pandemic, has threatened public health worldwide. Several drugs or vaccines have been approved to treat the serious illness COVID-19 caused by the SARS-CoV-2 virus. In particular, the 2023 Nobel Prize in Biomedicine was announced in early October this year in Stockholm (Sweden) awarded to two scientists, Katalin Kariko and Drew Weissman, who have successfully researched and developed mRNA technology vaccines that have contributed to saving humanity from pandemics in recent years, further affirming the direction in the future. The development of new pharmaceutical technology, which is drugs and biological products applying mRNA technology. Relying on virus and host structures to guide molecular research efforts, develop targeted drugs with new technologies, and apply achievements of mRNA genetic technology and immunology. All CoV enzymes and proteins involved in virus replication and controlling the host's cellular immune system are potential targets that can be targeted by molecular targets. medicine in the process of searching for treatment options for Covid 19 disease caused by SARS-CoV-2.